ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,797Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 337

$1.56M Total Retail Price of All Prescriptions

Rank: 4 out of 337

452 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 452 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

15% of this provider’s 452 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 24,617 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

62 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
WARFARIN SODIUM 1,596 1,357 1 11
FUROSEMIDE 919 861 2 8
SIMVASTATIN 808 723 3 1
LEVOTHYROXINE SODIUM 755 718 4 5
DONEPEZIL HCL 664 651 5 22
METOPROLOL TARTRATE 664 586 5 6
LISINOPRIL 634 552 7 2
TRAZODONE HCL 622 576 8 16
AMLODIPINE BESYLATE 538 511 9 3
OMEPRAZOLE 536 461 10 4
MIRTAZAPINE 491 463 11 27
GABAPENTIN 447 414 12 20
HYDROCODONE-ACETAMINOPHEN 437 331 S3 13 13
CITALOPRAM HBR 432 392 14 17
NAMENDA 428 426 15 35
SERTRALINE HCL 427 404 16 18
POLYETHYLENE GLYCOL 3350 400 360 17 47
QUETIAPINE FUMARATE 344 302 18 61
TAMSULOSIN HCL 330 317 19 25
LIDODERM 329 316 20 82
RISPERIDONE 302 274 21 72
BISOPROLOL FUMARATE 293 268 22 67
ATENOLOL 290 264 23 10
TRAMADOL HCL 279 271 24 32
ATORVASTATIN CALCIUM 260 194 25 7
FENOFIBRATE 253 198 26 48
EXELON 252 252 27 85
ESCITALOPRAM OXALATE 243 223 28 66
IPRATROPIUM-ALBUTEROL 218 211 29 96
HYDROCHLOROTHIAZIDE 217 190 30 9
LANTUS 213 207 31 49
METFORMIN HCL 212 191 32 12
PREDNISONE 211 171 33 40
ENULOSE 208 175 34 171
CARBIDOPA-LEVODOPA 208 208 34 92
KLOR-CON M20 202 157 36 65
POTASSIUM CHLORIDE 195 184 37 62
GLIPIZIDE 187 169 38 45
GENERLAC 186 165 39 164
CLOZAPINE 179 120 40 94
SPIRIVA 178 163 41 43
FINASTERIDE 168 168 42 83
RAMIPRIL 163 150 43 80
CYMBALTA 163 142 43 59
LOSARTAN POTASSIUM 155 151 45 15
DIGOXIN 148 139 46 58
SPIRONOLACTONE 148 137 46 100
ADVAIR DISKUS 146 134 48 44
ISOSORBIDE MONONITRATE ER 146 125 48 70
CRESTOR 146 87 48 29
VENLAFAXINE HCL ER 143 131 51 86
ALENDRONATE SODIUM 142 130 52 19
DIOVAN 140 126 53 26
ENABLEX 138 138 54 190
LEVETIRACETAM 138 90 54 112
LACTULOSE 135 119 56 105
RANITIDINE HCL 134 100 57 30
OXYBUTYNIN CHLORIDE ER 128 118 58 124
OLANZAPINE 127 97 59 108
SEROQUEL 124 112 60 107
CLOPIDOGREL 123 102 61 42
PANTOPRAZOLE SODIUM 120 109 62 36
GLIPIZIDE ER 112 103 63 69
DILTIAZEM 24HR CD 110 102 64 104
ALLOPURINOL 103 101 65 28
LOVASTATIN 103 103 65 24
ALBUTEROL SULFATE 99 83 67 131
NOVOLIN 70-30 97 97 68 198
BYSTOLIC 94 94 69 91
DIVALPROEX SODIUM 94 86 69 101
MECLIZINE HCL 93 83 71 117
BUMETANIDE 92 80 72 163
METOPROLOL SUCCINATE 92 86 72 21
NOVOLIN R 91 89 74 165
LATANOPROST 91 81 74 120
ZOLPIDEM TARTRATE 91 87 74 23
ROPINIROLE HCL 89 67 77 141
NOVOLOG 88 84 78 106
BETAMETHASONE DIPROPIONATE 87 69 79 244
TRAVATAN Z 86 72 80 160
PRAVASTATIN SODIUM 86 72 80 14
TAMIFLU 85 82 82 147
PHENYTOIN SODIUM EXTENDED 84 73 83 150
JANUVIA 82 82 84 81
PLAVIX 80 73 85 74
NYSTOP 80 73 85 140
DILTIAZEM HCL 79 79 87 177
OXYCODONE HCL 77 73 S2 88 63
CLOTRIMAZOLE 76 68 89 227
ENOXAPARIN SODIUM 73 55 90 253
CARVEDILOL 73 61 90 73
BRIMONIDINE TARTRATE 67 56 92 161
KLOR-CON M10 66 64 93 162
LANTUS SOLOSTAR 66 59 93 146
RIVASTIGMINE 65 65 95 208
FLUTICASONE PROPIONATE 64 58 96 34
CEPHALEXIN 62 55 97 130
LEXAPRO 61 55 98 169
GLYBURIDE 61 56 R 98 53
FORTICAL 60 60 100 217
ENALAPRIL MALEATE 60 45 100 37
PEN NEEDLE 59 55 102 236
HYDRALAZINE HCL 59 55 102 122
LIDOCAINE 58 34 104 225
CIPROFLOXACIN HCL 58 58 104 71
FENTANYL 58 39 S2 104 138
OXYCODONE-ACETAMINOPHEN 55 40 S2 107 84
AVELOX 55 53 107 184
CLOBETASOL PROPIONATE 55 44 107 241
TRAVASOL 55 55 107 308
ERYTHROMYCIN 54 47 111 202
BACLOFEN 53 27 112 133
TOPIRAMATE 52 28 113 228
TRILIPIX 50 50 114 186
CLONIDINE HCL 50 50 114 135
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 30, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.